CalciMedica, Inc. (CALC) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, CalciMedica reported revenue of $713,000. Net income was -$29.6M (a -4146.1% net margin), or -$9.85 per diluted share. Operating margin was -3242.8%. Operating activities generated -$21.2M of cash, leaving -$21.2M of free cash flow. At fiscal year end, CalciMedica held $13.6M in total assets against $20.2M in total liabilities, including $11.5M of cash and equivalents.
Open the full interactive CalciMedica financials → Quarterly statements, key ratios, valuation history and price charts.
CalciMedica Key Stats
| Share Price | $1.12 |
|---|---|
| Market Cap | $3.8M |
| 52-Week Range | $1.12 – $33.70 |
| Shares Outstanding | 3.4 million (basic, 2026 Q2) |
CalciMedica Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $713,000 |
| Operating Income | -$29.8M | -$35.9M | -$36.2M | -$38.1M | -$24.2M | -$23.1M |
| Pre-Tax Income | -$27.5M | -$35.8M | -$35.6M | -$34.4M | -$13.7M | -$29.6M |
| Income Tax | — | — | — | $1,000 | $0 | $0 |
| Net Income | -$27.5M | -$35.8M | -$35.6M | -$34.4M | -$13.7M | -$29.6M |
| Diluted EPS | -$26.25 | -$8.45 | -$8.30 | -$38.30 | -$6.10 | -$9.85 |
CalciMedica Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $140,000 | $151,000 | $106,000 | $54,000 |
| Net Income | -$7.8M | -$10.8M | $5.0M | -$7.7M |
| Diluted EPS | -$2.60 | -$0.72 | $1.50 | -$2.25 |
CalciMedica Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $33.4M | $13.4M | $17.3M | $5.5M | $7.9M | $11.5M |
| Current Assets | $99.2M | $67.1M | $39.7M | $11.6M | $19.7M | $13.5M |
| Total Assets | $101.8M | $69.1M | $39.7M | $12.2M | $19.8M | $13.6M |
| Current Liabilities | $7.0M | $4.1M | $3.7M | $4.0M | $3.7M | $3.8M |
| Total Liabilities | $7.0M | $4.1M | $3.7M | $4.0M | $5.4M | $20.2M |
| Shareholders' Equity | $94.8M | $65.0M | $36.0M | $8.2M | $14.4M | -$6.6M |
CalciMedica Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$32.1M | -$31.5M | -$22.9M | -$25.7M | -$21.1M | -$21.2M |
| Cash From Investing | -$42.6M | $10.8M | $27.0M | $8.9M | -$4.4M | $9.6M |
| Cash From Financing | $92.2M | $695,000 | -$139,000 | $20.9M | $28.0M | $15.2M |
| Free Cash Flow | -$33.1M | -$32.0M | -$23.2M | -$25.8M | -$21.2M | -$21.2M |
Figures from CalciMedica's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full CalciMedica financials page for every line item.
CalciMedica Company Profile
| Ticker | CALC |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | La Jolla, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001534133 |
Frequently Asked Questions
What was CalciMedica's revenue in fiscal 2025?
CalciMedica (CALC) reported revenue of $713,000 for fiscal 2025.
What is CalciMedica's annual revenue history?
CalciMedica's annual revenue by fiscal year: 2020: $0; 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $713,000.
What was CalciMedica's net income in fiscal 2025?
CalciMedica reported net income of -$29.6M for fiscal 2025.
What was CalciMedica's earnings per share (EPS) in fiscal 2025?
CalciMedica's diluted EPS was -$9.85 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did CalciMedica generate in fiscal 2025?
CalciMedica generated -$21.2M of free cash flow in fiscal 2025.
What was CalciMedica's revenue last quarter?
In its most recent reported quarter (2026 Q2), CalciMedica reported revenue of $54,000.
How many shares of CalciMedica are outstanding?
CalciMedica reported a weighted average of 3.4 million basic shares outstanding in 2026 Q2.
What is CalciMedica's market cap?
Based on its latest closing price, CalciMedica (CALC) has a market capitalization of about $3.8M.
When does CalciMedica's fiscal year end?
CalciMedica's fiscal year end, as registered with the SEC, is December 31.
Where is CalciMedica headquartered?
CalciMedica lists its business address in La Jolla, California in its SEC filings.